Remove 2024 Remove Packaging Remove Pharmaceutical Manufacturing
article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.

article thumbnail

Guide the pharma world with PHARMAP 2024

Express Pharma

Leaders of the whole pharma value chain meet at Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) to find new connections and discuss trends of the industry. Rocco Paracchinin already registered as a speaker for PHARMAP 2024 and will talk about tech transfer goods and odds.

Packaging 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Steriline to exhibit its Robotic Vial Filling Machine at ACHEMA 2024

Express Pharma

Steriline, the European manufacturer of standard and robotic lines for the aseptic processing of injectable drugs, will exhibit at Achema 2024, from June 10 to 14.It It will showcase the new technologies developed to upgrade its zero-loss philosophy, to better meet the sustainability needs of the pharmaceutical industry.

Packaging 105
article thumbnail

FOPE and PharmaState Academy hosts Session 11 of the PULSE series

Express Pharma

On December 15, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 11 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on Good Practices In Quality Control.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database.

article thumbnail

Glance in the future: Explore innovative solutions at PHARMAP 2023

Express Pharma

The first day of the Congress started with the executive opening panel, where speakers from LabWare, Optel Group, 3V Tech, GSK, PharmaLedger Association, Bushu Pharmaceuticals, PHARMAZAC had a discussion about new models for pharma manufacturing and packaging.

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.

Dosage 104